172 related articles for article (PubMed ID: 20526690)
1. Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users.
Riley ED; Kral AH; Stopka TJ; Garfein RS; Reuckhaus P; Bluthenthal RN
J Urban Health; 2010 Jul; 87(4):534-42. PubMed ID: 20526690
[TBL] [Abstract][Full Text] [Related]
2. Syringe disposal among people who inject drugs in Los Angeles: the role of sterile syringe source.
Quinn B; Chu D; Wenger L; Bluthenthal RN; Kral AH
Int J Drug Policy; 2014 Sep; 25(5):905-10. PubMed ID: 24930425
[TBL] [Abstract][Full Text] [Related]
3. Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco counties, 2007.
Cooper EN; Dodson C; Stopka TJ; Riley ED; Garfein RS; Bluthenthal RN
J Urban Health; 2010 Jul; 87(4):543-52. PubMed ID: 20549568
[TBL] [Abstract][Full Text] [Related]
4. Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CA.
Siddiqui SS; Armenta RF; Evans JL; Yu M; Cuevas-Mota J; Page K; Davidson P; Garfein RS
Int J Drug Policy; 2015 Nov; 26(11):1150-7. PubMed ID: 26252980
[TBL] [Abstract][Full Text] [Related]
5. Pharmacy syringe purchase test of nonprescription syringe sales in San Francisco and Los Angeles in 2010.
Lutnick A; Cooper E; Dodson C; Bluthenthal R; Kral AH
J Urban Health; 2013 Apr; 90(2):276-83. PubMed ID: 22718357
[TBL] [Abstract][Full Text] [Related]
6. Syringe acquisition experiences and attitudes among injection drug users undergoing short-term opioid detoxification in Massachusetts and Rhode Island.
Zaller ND; Yokell MA; Nayak SM; Fu JJ; Bazazi AR; Rich JD
J Urban Health; 2012 Aug; 89(4):659-70. PubMed ID: 22427232
[TBL] [Abstract][Full Text] [Related]
7. A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs.
Tookes HE; Kral AH; Wenger LD; Cardenas GA; Martinez AN; Sherman RL; Pereyra M; Forrest DW; LaLota M; Metsch LR
Drug Alcohol Depend; 2012 Jun; 123(1-3):255-9. PubMed ID: 22209091
[TBL] [Abstract][Full Text] [Related]
8. Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.
Rudolph AE; Crawford ND; Ompad DC; Benjamin EO; Stern RJ; Fuller CM
J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):140-7. PubMed ID: 20199954
[TBL] [Abstract][Full Text] [Related]
9. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
[TBL] [Abstract][Full Text] [Related]
10. Investigation of a secondary syringe exchange program for homeless young adult injection drug users in San Francisco, California, U.S.A.
Sears C; Guydish JR; Weltzien EK; Lum PJ
J Acquir Immune Defic Syndr; 2001 Jun; 27(2):193-201. PubMed ID: 11404542
[TBL] [Abstract][Full Text] [Related]
11. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.
Lurie P; Gorsky R; Jones TS; Shomphe L
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S126-32. PubMed ID: 9663635
[TBL] [Abstract][Full Text] [Related]
12. Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999.
Cotten-Oldenburg NU; Carr P; DeBoer JM; Collison EK; Novotny G
J Acquir Immune Defic Syndr; 2001 Jun; 27(2):183-92. PubMed ID: 11404541
[TBL] [Abstract][Full Text] [Related]
13. Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.
Pollini RA
J Am Pharm Assoc (2003); 2017; 57(6):677-685. PubMed ID: 28807658
[TBL] [Abstract][Full Text] [Related]
14. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients.
Bluthenthal RN; Anderson R; Flynn NM; Kral AH
Drug Alcohol Depend; 2007 Jul; 89(2-3):214-22. PubMed ID: 17280802
[TBL] [Abstract][Full Text] [Related]
15. Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales.
Costenbader EC; Zule WA; Coomes CC
Int J Drug Policy; 2010 Sep; 21(5):425-8. PubMed ID: 20097052
[TBL] [Abstract][Full Text] [Related]
16. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.
Singer M; Baer HA; Scott G; Horowitz S; Weinstein B
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):81-9. PubMed ID: 9722813
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities.
Zlotorzynska M; Weidle PJ; Paz-Bailey G; Broz D;
Int J Drug Policy; 2018 Dec; 62():51-58. PubMed ID: 30359873
[TBL] [Abstract][Full Text] [Related]
18. Syringe source, use, and discard among injection-drug users in New Haven, Connecticut.
Khoshnood K; Blankenship KM; Pollack HA; Roan CT; Altice FL
AIDS Public Policy J; 2000; 15(3-4):88-94. PubMed ID: 12189714
[TBL] [Abstract][Full Text] [Related]
19. A longitudinal study of syringe acquisition by Puerto Rican injection drug users in New York and Puerto Rico: implications for syringe exchange and distribution programs.
Finlinson HA; Oliver-Vélez D; Deren S; Cant JG; Colón HM; Robles RR; Kang SY; Andía JF
Subst Use Misuse; 2006; 41(9):1313-36. PubMed ID: 16861181
[TBL] [Abstract][Full Text] [Related]
20. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995.
Bluthenthal RN; Kral AH; Erringer EA; Edlin BR
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):505-11. PubMed ID: 9715848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
